Amjad Alwaal1, Jack W McAninch2, Catherine R Harris2, Benjamin N Breyer2. 1. Department of Urology, University of California San Francisco, San Francisco, CA; Department of Urology, King Abdul Aziz University, Jeddah, Saudi Arabia. Electronic address: amjadwal@yahoo.com. 2. Department of Urology, University of California San Francisco, San Francisco, CA.
Abstract
OBJECTIVE: To report our successful outcomes of genital split-thickness skin graft (STSG) in covering major skin loss and providing good functional and cosmetic outcomes. MATERIALS AND METHODS: A retrospective chart review was performed for all adult urology patients who underwent STSG at our institution from 1998 to 2014. Patients had a wide range of disease etiologies, including tissue loss (eg post-Fournier's gangrene), lymphedema, buried penis, foreign body injection, and tumors. RESULTS: A total of 54 patients were identified with the following breakdown of etiology: 13 patients with tissue loss (eg post-Fournier's gangrene), 13 with lymphedema, 12 with buried penis, 8 with foreign body injection, 4 with hidradenitis suppurativa, and 4 with tumors. Fifty-two out of 54 patients had more than 90% graft take, with maintained or improved erection, normal voiding, good cosmetic outcome as judged by the patient and the examining surgeon, and normal mobility. One patient died at 3 months due to cardiovascular cause, and 1 patient had a poor take of the graft. CONCLUSION: We show the wide variety of indications for STSG use, the ease of the technique, and its successful outcomes. We believe this procedure should be offered to patients as a first-line treatment and also as a last resort when other more conservative approaches fail.
OBJECTIVE: To report our successful outcomes of genital split-thickness skin graft (STSG) in covering major skin loss and providing good functional and cosmetic outcomes. MATERIALS AND METHODS: A retrospective chart review was performed for all adult urology patients who underwent STSG at our institution from 1998 to 2014. Patients had a wide range of disease etiologies, including tissue loss (eg post-Fournier's gangrene), lymphedema, buried penis, foreign body injection, and tumors. RESULTS: A total of 54 patients were identified with the following breakdown of etiology: 13 patients with tissue loss (eg post-Fournier's gangrene), 13 with lymphedema, 12 with buried penis, 8 with foreign body injection, 4 with hidradenitis suppurativa, and 4 with tumors. Fifty-two out of 54 patients had more than 90% graft take, with maintained or improved erection, normal voiding, good cosmetic outcome as judged by the patient and the examining surgeon, and normal mobility. One patient died at 3 months due to cardiovascular cause, and 1 patient had a poor take of the graft. CONCLUSION: We show the wide variety of indications for STSG use, the ease of the technique, and its successful outcomes. We believe this procedure should be offered to patients as a first-line treatment and also as a last resort when other more conservative approaches fail.
Authors: Adam Bryce Weinfeld; Patrick Kelley; Eser Yuksel; Pankaj Tiwari; Patrick Hsu; Joshua Choo; Larry H Hollier Journal: Ann Plast Surg Date: 2005-02 Impact factor: 1.539
Authors: Lindsay A Hampson; Wade Muncey; Paul H Chung; C C Ma; Jeffrey Friedrich; Hunter Wessells; Bryan B Voelzke Journal: Urology Date: 2017-08-07 Impact factor: 2.649
Authors: Carlo Bettocchi; Andrea Alberto Checchia; Ugo Giovanni Falagario; Anna Ricapito; Gian Maria Busetto; Luigi Cormio; Giuseppe Carrieri Journal: Int J Impot Res Date: 2022-04-05 Impact factor: 2.408
Authors: Arman T Serebrakian; Brent B Pickrell; David E Varon; Amin Mohamadi; Mark W Grinstaff; Edward K Rodriguez; Ara Nazarian; Eric G Halvorson; Indranil Sinha Journal: Plast Reconstr Surg Glob Open Date: 2018-09-24